Works matching AU Zanwar, Saurabh

Results: 48
    1

    Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer.

    Published in:
    Clinical Lung Cancer, 2023, v. 24, n. 8, p. 689, doi. 10.1016/j.cllc.2023.09.001
    By:
    • Desai, Aakash;
    • Smith, Caleb J.;
    • Ashara, Yash;
    • Orme, Jacob J.;
    • Zanwar, Saurabh;
    • Potter, Ashley;
    • Hocum, Craig;
    • Moffett, J. Nicole;
    • Schwecke, Anna J.;
    • Manochakian, Rami;
    • Yanyan Lou;
    • Yujie Zhao;
    • Ernani, Vinicius;
    • Sawides, Panos;
    • Molina, Julian;
    • Dimou, Anastasios;
    • Mansfield, Aaron S.;
    • Parikh, Kaushal;
    • Leventakos, Konstantinos
    Publication type:
    Article
    2
    3
    4
    5

    Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00752-z
    By:
    • Zanwar, Saurabh;
    • Ho, Matthew;
    • Buadi, Francis K.;
    • Ailawadhi, Sikander;
    • Larsen, Jeremy;
    • Bergsagel, Leif;
    • Binder, Moritz;
    • Chanan-Khan, Asher;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Fonseca, Rafael;
    • Gertz, Morie A.;
    • Gonsalves, Wilson;
    • Go, Ronald S.;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Lacy, Martha Q.;
    • Leung, Nelson;
    • Lin, Yi
    Publication type:
    Article
    6

    Clinical and therapeutic implications of BRAF fusions in histiocytic disorders.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00693-7
    By:
    • Zanwar, Saurabh;
    • Abeykoon, Jithma P.;
    • Dasari, Surendra;
    • Ravindran, Aishwarya;
    • Young, Jason R.;
    • Acosta-Medina, Aldo A.;
    • Rech, Karen L.;
    • Schwartz, Jonathan;
    • Mangold, Aaron;
    • Rosenthal, Allison;
    • Bennani, N. Nora;
    • Shah, Mithun V.;
    • Morlote, Diana;
    • Goyal, Gaurav;
    • Go, Ronald S.
    Publication type:
    Article
    7

    The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM).

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00548-7
    By:
    • Ho, Matthew;
    • Zanwar, Saurabh;
    • Kapoor, Prashant;
    • Gertz, Morie;
    • Lacy, Martha;
    • Dispenzieri, Angela;
    • Hayman, Suzanne;
    • Dingli, David;
    • Baudi, Francis;
    • Muchtar, Eli;
    • Leung, Nelson;
    • Kourelis, Taxiarchis;
    • Warsame, Rahma;
    • Fonder, Amie;
    • Hwa, Lisa;
    • Hobbs, Miriam;
    • Kyle, Robert;
    • Rajkumar, S. Vincent;
    • Kumar, Shaji
    Publication type:
    Article
    8
    9
    10
    11
    12

    Predictors of short-term survival in Waldenström Macroglobulinemia.

    Published in:
    2020
    By:
    • Ruan, Gordon;
    • Zanwar, Saurabh;
    • Abeykoon, Jithma P.;
    • Ansell, Stephen M.;
    • Gertz, Morie;
    • Go, Ronald S.;
    • Muchtar, Eli;
    • Gonsalves, Wilson I.;
    • Paludo, Jonas;
    • Thanarajasingam, Gita;
    • Inwards, David J.;
    • Thompson, Carrie A.;
    • Habermann, Thomas M.;
    • Lin, Yi;
    • Nowakowski, Grzegorz S.;
    • Bisneto, Jose C. Villasboas;
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Buadi, Francis K.;
    • Dingli, David
    Publication type:
    Letter
    13
    14

    Autologous and Allogeneic Stem‐Cell Transplantation for Transformed Waldenström Macroglobulinemia.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 2, p. 338, doi. 10.1002/ajh.27543
    By:
    • Durot, Eric;
    • Kanagaratnam, Lukshe;
    • Zanwar, Saurabh;
    • Kaufman, Adrienne;
    • D'Sa, Shirley;
    • Toussaint, Elise;
    • Roos‐Weil, Damien;
    • Alcoceba, Miguel;
    • Vos, Josephine M. I.;
    • Michallet, Anne‐Sophie;
    • Talaulikar, Dipti;
    • Kastritis, Efstathios;
    • Khwaja, Jahanzaib;
    • Treon, Steven P.;
    • Garcia‐Sanz, Ramon;
    • Morel, Pierre;
    • Munoz, Javier;
    • Castillo, Jorge J.;
    • Kapoor, Prashant;
    • Delmer, Alain
    Publication type:
    Article
    15
    16

    Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 10, p. 1540, doi. 10.1002/ajh.27023
    By:
    • Zanwar, Saurabh;
    • Ho, Matthew;
    • Lin, Yi;
    • Kapoor, Prashant;
    • Binder, Moritz;
    • Buadi, Francis K.;
    • Dispenzieri, Angela;
    • Dingli, David;
    • Fonder, Amie;
    • Gertz, Morie A.;
    • Gonsalves, Wilson;
    • Hayman, Suzanne R.;
    • Hwa, Yi;
    • Hobbs, Miriam;
    • Kourelis, Taxiarchis;
    • Lacy, Martha Q.;
    • Leung, Nelson;
    • Muchtar, Eli;
    • Warsame, Rahma;
    • Jevremovic, Dragan
    Publication type:
    Article
    17

    Risk factors for severe infection and mortality In patients with COVID‐19 in patients with multiple myeloma and AL amyloidosis.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. 49, doi. 10.1002/ajh.26762
    By:
    • Ho, Matthew;
    • Zanwar, Saurabh;
    • Buadi, Francis K.;
    • Ailawadhi, Sikander;
    • Larsen, Jeremy;
    • Bergsagel, Leif;
    • Binder, Moritz;
    • Chanan‐Khan, Asher;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Fonseca, Rafael;
    • Gertz, Morie A.;
    • Gonsalves, Wilson;
    • Go, Ronald S.;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Lacy, Martha Q.;
    • Leung, Nelson;
    • Lin, Yi
    Publication type:
    Article
    18
    19

    Assessment of fixed‐duration therapies for treatment‐naïve Waldenström macroglobulinemia.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. 945, doi. 10.1002/ajh.26210
    By:
    • Abeykoon, Jithma P.;
    • Zanwar, Saurabh;
    • Ansell, Stephen M.;
    • Muchtar, Eli;
    • He, Rong;
    • Greipp, Patricia T.;
    • King, Rebecca L.;
    • Ailawadhi, Sikander;
    • Paludo, Jonas;
    • Larsen, Jeremy T.;
    • Habermann, Thomas M.;
    • Inwards, David;
    • Go, Ronald S.;
    • Thanarajasingam, Gita;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Thompson, Carrie A.;
    • Witzig, Thomas E.;
    • Lacy, Martha;
    • Gonsalves, Wilson
    Publication type:
    Article
    20

    Impact of MYD88<sup>L265P</sup> mutation status on histological transformation of Waldenström Macroglobulinemia.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 3, p. 274, doi. 10.1002/ajh.25697
    By:
    • Zanwar, Saurabh;
    • Abeykoon, Jithma P.;
    • Durot, Eric;
    • King, Rebecca;
    • Perez Burbano, Gabriela E.;
    • Kumar, Shaji;
    • Gertz, Morie A.;
    • Quinquenel, Anne;
    • Delmer, Alain;
    • Gonsalves, Wilson;
    • Cornillet‐Lefebvre, Pascale;
    • He, Rong;
    • Warsame, Rahma;
    • Buadi, Francis K.;
    • Novak, Anne J.;
    • Greipp, Patricia T.;
    • Inwards, David;
    • Habermann, Thomas M.;
    • Micallef, Ivana;
    • Go, Ronald
    Publication type:
    Article
    21

    Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 11, p. 1384, doi. 10.1002/ajh.25254
    By:
    • Abeykoon, Jithma P.;
    • Zanwar, Saurabh;
    • Ansell, Stephen M.;
    • Winters, Jeffrey;
    • Gertz, Morie A.;
    • King, Rebecca L.;
    • Murray, David;
    • Habermann, Thomas;
    • Dingli, David;
    • Muchtar, Eli;
    • Go, Ronald S.;
    • Leung, Nelson;
    • Inwards, David J;
    • Buadi, Francis K.;
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Lin, Yi;
    • Gonsalves, Wilson I.;
    • Kourelis, Taxiarchis;
    • Witzig, Thomas E.
    Publication type:
    Article
    22

    Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01264-2
    By:
    • Bolarinwa, Abiola;
    • Nagaraj, Madhu;
    • Zanwar, Saurabh;
    • Abdallah, Nadine;
    • Bergsagel, P. Leif;
    • Binder, Moritz;
    • Buadi, Francis;
    • Chhabra, Saurabh;
    • Cook, Joselle;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Gertz, Morie A.;
    • Gonsalves, Wilson;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Leung, Nelson;
    • Lin, Yi;
    • Muchtar, Eli;
    • Parrondo, Ricardo
    Publication type:
    Article
    23

    Clonal plasma cell proportion in the synthetic phase identifies a unique high-risk cohort in multiple myeloma.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01232-w
    By:
    • Zanwar, Saurabh;
    • Jevremovic, Dragan;
    • Kapoor, Prashant;
    • Olteanu, Horatiu;
    • Buadi, Francis;
    • Horna, Pedro;
    • Gonsalves, Wilson;
    • Otteson, Gregory;
    • Bolarinwa, Abiola Bukunmi;
    • Hayman, Suzanne;
    • Abdallah, Nadine;
    • Binder, Moritz;
    • Cook, Joselle;
    • Dispenzieri, Angela;
    • Dingli, David;
    • Gertz, Morie A.;
    • Kourelis, Taxiarchis;
    • Leung, Nelson;
    • Lin, Yi;
    • Muchtar, Eli
    Publication type:
    Article
    24

    MM-431: A Comparison Between Daratumumab and Non-Daratumumab-Based Salvage Regimens Used at First Relapse Post-Lenalidomide Maintenance in Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S444, doi. 10.1016/S2152-2650(21)01987-X
    By:
    • Ho, Matthew;
    • Zanwar, Saurabh;
    • Kapoor, Prashant;
    • Gertz, Morie;
    • Lacy, Martha;
    • Dispenzieri, Angela;
    • Hayman, Suzanne;
    • Dingli, David;
    • Buadi, Francis;
    • Leung, Nelson;
    • Kourelis, Taxiarchis;
    • Warsame, Rahma;
    • Fonder, Amie;
    • Hwa, Lisa;
    • Hobbs, Miriam;
    • Kyle, Robert;
    • Rajkumar, Vincent;
    • Kumar, Shaji
    Publication type:
    Article
    25

    MM-429: Impact of Prolonged Lenalidomide Maintenance (≥3 years) and Outcomes in Patients with Multiple Myeloma Post-Autologous Stem Cell Transplant.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S443, doi. 10.1016/S2152-2650(21)01986-8
    By:
    • Zanwar, Saurabh;
    • Ho, Matthew;
    • Kapoor, Prashant;
    • Gertz, Morie;
    • Lacy, Martha;
    • Dispenzieri, Angela;
    • Hayman, Suzanne;
    • Dingli, David;
    • Buadi, Francis;
    • Leung, Nelson;
    • Kourelis, Taxiarchis;
    • Warsame, Rahma;
    • Fonder, Amie;
    • Yi Hwa;
    • Hobbs, Miriam;
    • Kyle, Robert;
    • Rajkumar, Vincent;
    • Kumar, Shaji
    Publication type:
    Article
    26

    IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S401, doi. 10.1016/S2152-2650(21)01906-6
    By:
    • Abeykoon, Jithma;
    • Zanwar, Saurabh;
    • Ansell, Stephen;
    • Muchtar, Eli;
    • Rong He;
    • Greipp, Patricia;
    • King, Rebecca;
    • Ailawadhi, Sikander;
    • Paludo, Jonas;
    • Larsen, Jeremy;
    • Habermann, Thomas;
    • Inwards, David;
    • Go, Ronald;
    • Thanarajasingam, Gita;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Thompson, Carrie;
    • Witzig, Thomas;
    • Lacy, Martha;
    • Gonsalves, Wilson
    Publication type:
    Article
    27

    Poster: MM-431: A Comparison Between Daratumumab and Non-Daratumumab-Based Salvage Regimens Used at First Relapse Post-Lenalidomide Maintenance in Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S256, doi. 10.1016/S2152-2650(21)01611-6
    By:
    • Ho, Matthew;
    • Zanwar, Saurabh;
    • Kapoor, Prashant;
    • Gertz, Morie;
    • Lacy, Martha;
    • Dispenzieri, Angela;
    • Hayman, Suzanne;
    • Dingli, David;
    • Buadi, Francis;
    • Leung, Nelson;
    • Kourelis, Taxiarchis;
    • Warsame, Rahma;
    • Fonder, Amie;
    • Hwa, Lisa;
    • Hobbs, Miriam;
    • Kyle, Robert;
    • Rajkumar, Vincent;
    • Kumar, Shaji
    Publication type:
    Article
    28

    Poster: MM-429: Impact of Prolonged Lenalidomide Maintenance (≥3 years) and Outcomes in Patients with Multiple Myeloma Post-Autologous Stem Cell Transplant.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S252, doi. 10.1016/S2152-2650(21)01580-9
    By:
    • Zanwar, Saurabh;
    • Ho, Matthew;
    • Kapoor, Prashant;
    • Gertz, Morie;
    • Lacy, Martha;
    • Dispenzieri, Angela;
    • Hayman, Suzanne;
    • Dingli, David;
    • Buadi, Francis;
    • Leung, Nelson;
    • Kourelis, Taxiarchis;
    • Warsame, Rahma;
    • Fonder, Amie;
    • Hwa, Yi;
    • Hobbs, Miriam;
    • Kyle, Robert;
    • Rajkumar, Vincent;
    • Kumar, Shaji
    Publication type:
    Article
    29

    Poster: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S244, doi. 10.1016/S2152-2650(21)01536-6
    By:
    • Abeykoon, Jithma;
    • Zanwar, Saurabh;
    • Ansell, Stephen;
    • Muchtar, Eli;
    • He, Rong;
    • Greipp, Patricia;
    • King, Rebecca;
    • Ailawadhi, Sikander;
    • Paludo, Jonas;
    • Larsen, Jeremy;
    • Habermann, Thomas;
    • Inwards, David;
    • Go, Ronald;
    • Thanarajasingam, Gita;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Thompson, Carrie;
    • Witzig, Thomas;
    • Lacy, Martha;
    • Gonsalves, Wilson
    Publication type:
    Article
    30

    Oral Abstract: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S203, doi. 10.1016/S2152-2650(21)01277-5
    By:
    • Abeykoon, Jithma;
    • Zanwar, Saurabh;
    • Ansell, Stephen;
    • Muchtar, Eli;
    • Rong He;
    • Greipp, Patricia;
    • King, Rebecca;
    • Ailawadhi, Sikander;
    • Paludo, Jonas;
    • Larsen, Jeremy;
    • Habermann, Thomas;
    • Inwards, David;
    • Go, Ronald;
    • Thanarajasingam, Gita;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Thompson, Carrie;
    • Witzig, Thomas;
    • Lacy, Martha;
    • Gonsalves, Wilson
    Publication type:
    Article
    31

    Progression risk stratification of Asymptomatic Waldenström Macroglobulinemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e38, doi. 10.1016/j.clml.2019.09.058
    By:
    • Sklavenitis-Pistofidis, Romanos;
    • Bustoros, Mark;
    • Kapoor, Prashant;
    • Liu, Chia-Jen;
    • Kastritis, Efstathios;
    • Zanwar, Saurabh;
    • Fell, Geoffrey;
    • Abeykoon, Jithma;
    • Hornburg, Kalvis;
    • Neuse, Carl;
    • Marinac, Catherine R.;
    • Liu, David;
    • Soiffer, Jenny;
    • Gavriatopoulou, Maria;
    • Boehner, Cody;
    • Cappuccio, Joseph;
    • Dumke, Henry;
    • Reyes, Kaitlen;
    • Soiffer, Robert;
    • Kyle, Robert
    Publication type:
    Article
    32
    33

    Ixazomib: a novel drug for multiple myeloma.

    Published in:
    Expert Review of Hematology, 2018, v. 11, n. 10, p. 761, doi. 10.1080/17474086.2018.1518129
    By:
    • Zanwar, Saurabh;
    • Abeykoon, Jithma Prasad;
    • Kapoor, Prashant
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemia.

    Published in:
    British Journal of Haematology, 2021, v. 195, n. 2, p. 210, doi. 10.1111/bjh.17691
    By:
    • Zanwar, Saurabh;
    • Abeykoon, Jithma P.;
    • Ansell, Stephen M.;
    • Gertz, Morie A.;
    • Colby, Colin;
    • Larson, Dirk;
    • Paludo, Jonas;
    • He, Rong;
    • Warsame, Rahma;
    • Greipp, Patricia T.;
    • King, Rebecca L.;
    • Thompson, Carrie A.;
    • Witzig, Thomas E.;
    • Lacy, Martha Q.;
    • Gonsalves, Wilson;
    • Nowakowski, Grzegorz S.;
    • Dingli, David;
    • Go, Ronald S.;
    • Habermann, Thomas M.;
    • Vincent Rajkumar, S.
    Publication type:
    Article
    43

    Partial response or better at six months is prognostic of superior progression‐free survival in Waldenström macroglobulinaemia patients treated with ibrutinib.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 3, p. 542, doi. 10.1111/bjh.17225
    By:
    • Castillo, Jorge J.;
    • Abeykoon, Jithma P.;
    • Gustine, Joshua N.;
    • Zanwar, Saurabh;
    • Mein, Kirsten;
    • Flynn, Catherine A.;
    • Demos, Maria G.;
    • Guerrera, Maria L.;
    • Kofides, Amanda;
    • Liu, Xia;
    • Munshi, Manit;
    • Tsakmaklis, Nickolas;
    • King, Rebecca;
    • Yang, Guang;
    • Hunter, Zachary R.;
    • Advani, Ranjana H.;
    • Palomba, Maria Lia;
    • Ansell, Stephen M.;
    • Gertz, Morie A.;
    • Kapoor, Prashant
    Publication type:
    Article
    44

    Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes.

    Published in:
    British Journal of Haematology, 2020, v. 188, n. 3, p. 394, doi. 10.1111/bjh.16168
    By:
    • Abeykoon, Jithma P.;
    • Zanwar, Saurabh;
    • Ansell, Stephen M.;
    • Gertz, Morie A.;
    • Kumar, Shaji;
    • Manske, Michelle;
    • Novak, Anne J.;
    • King, Rebecca;
    • Greipp, Patricia;
    • Go, Ronald;
    • Inwards, David;
    • Muchtar, Eli;
    • Habermann, Thomas;
    • Witzig, Thomas E.;
    • Thompson, Carrie A.;
    • Dingli, David;
    • Lacy, Martha Q.;
    • Leung, Nelson;
    • Dispenzieri, Angela;
    • Gonsalves, Wilson
    Publication type:
    Article
    45
    46
    47
    48